Ferritin in atherosclerosis

被引:111
作者
You, SA
Wang, Q
机构
[1] Cleveland Clin Fdn, Ctr Mol Genet, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA
关键词
ferritin; iron; atherosclerosis; coronary artery disease; proteomics;
D O I
10.1016/j.cccn.2005.02.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Iron, an essential element for many important cellular functions in all living organisms, can catalyze the formation of potentially toxic free radicals. Excessive iron is sequestered by ferritin in a nontoxic and readily available form in a cell. Ferritin is composed of 24 subunits of different proportions of two functionally distinct subunits: ferritin H and L. The former is involved in ferroxidase activity necessary for iron uptake and oxidation of ferrous iron, while the latter is involved in nucleation of the iron core. The expression of ferritin is under delicate control and is regulated at both the transcriptional and posttranscriptional levels by iron, cytokines and oxidative stress. Elevated ferritin levels are associated with an increased risk of atherosclerotic coronary artery disease (CAD), the leading cause of death and illness in developed countries. Serum ferritin levels are a good indicator of iron stores in the body. In fact, epidemiological studies have suggested that elevated serum ferritin levels are associated with an increased risk of CAD and myocardial infarction (MI), though inconsistent results were obtained in some other studies. Moreover, recent proteomics and molecular biology studies have shown that ferritin levels in arteries are increased in diseased tissues, which further supports the link of ferritin to CAD/MI. Future studies will determine whether increased ferritin levels can serve as a distinct biomarker for the incidence of CAD/MI and distinguish whether increased ferritin levels are a cause of CAD or a consequence of the disease process. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 155 条
[81]   Possible association of a reduction in cardiovascular events with blood donation [J].
Meyers, DG ;
Strickland, D ;
Maloley, PA ;
Seburg, JJ ;
Wilson, JE ;
McManus, BF .
HEART, 1997, 78 (02) :188-193
[82]   Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis [J].
Meyron-Holtz, EG ;
Ghosh, MC ;
Iwai, K ;
LaVaute, T ;
Brazzolotto, X ;
Berger, UV ;
Land, W ;
Ollivierre-Wilson, H ;
Grinberg, A ;
Love, P ;
Rouault, TA .
EMBO JOURNAL, 2004, 23 (02) :386-395
[83]   NO ASSOCIATION BETWEEN SERUM FERRITIN AND ASYMPTOMATIC CAROTID ATHEROSCLEROSIS - THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY [J].
MOORE, M ;
FOLSOM, AR ;
BARNES, RW ;
ECKFELDT, JH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (08) :719-723
[84]   Elevated serum ferritin level in acute myocardial infarction [J].
Moroz, C ;
Bessler, H ;
Katz, M ;
Zahavi, I ;
Salman, H ;
Djaldetti, M .
BIOMEDICINE & PHARMACOTHERAPY, 1997, 51 (03) :126-130
[85]   SERUM IRON AND RISK OF FATAL ACUTE MYOCARDIAL-INFARCTION [J].
MORRISON, HI ;
SEMENCIW, RM ;
MAO, Y ;
WIGLE, DT .
EPIDEMIOLOGY, 1994, 5 (02) :243-246
[86]  
MUNTANERELAT J, 1995, HEPATOLOGY, V22, P1143
[87]  
Nassar BA, 1998, CAN J CARDIOL, V14, P215
[88]   Increased ferritin gene expression in atherosclerotic lesions [J].
Pang, JHS ;
Jiang, MJ ;
Chen, YL ;
Wang, FW ;
Wang, DL ;
Chu, SH ;
Chau, LY .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) :2204-2212
[89]   Activation of iron regulatory protein-1 by oxidative stress in vitro [J].
Pantopoulos, K ;
Hentze, MW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10559-10563
[90]   RAPID RESPONSES TO OXIDATIVE STRESS MEDIATED BY IRON REGULATORY PROTEIN [J].
PANTOPOULOS, K ;
HENTZE, MW .
EMBO JOURNAL, 1995, 14 (12) :2917-2924